PathAI
PathAI's goal is to improve cancer diagnosis using artificial intelligence.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.0—1.5b (Dealroom.co estimates May 2021.)
Boston Massachusetts (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenues | 16.4m | 43.2m | 50.0m |
| % growth | - | 163 % | 16 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.5m | Seed | |
$4.2m | Seed | ||
$11.0m Valuation: $60.0m | Series A | ||
| N/A | JPY130m | Early VC | |
$60.0m | Series B | ||
N/A | Early VC | ||
$15.0m | Series B | ||
$165m | Series C | ||
* | N/A | $100m | Debt |
| Total Funding | AUD400m | ||
Recent News about PathAI
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by PathAI
Edit
ACQUISITION by Quest Diagnostics Jun 2024